Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.

Moroni, M.c., Hickman, E.s., Denchi, E.l., Caprara, G., Colli, E., Cecconi, F., et al. (2001). Apaf-1 is a transcriptional target for E2F and p53. NATURE CELL BIOLOGY, 3(6), 552-558 [10.1038/35078527].

Apaf-1 is a transcriptional target for E2F and p53

CECCONI, FRANCESCO;
2001-01-01

Abstract

Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
2001
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/06 - ANATOMIA COMPARATA E CITOLOGIA
English
Con Impact Factor ISI
apoptosis protease activating factor 1; holoenzyme; messenger RNA; protein p53; retinoblastoma protein; transcription factor E2F; unclassified drug; apoptosis; article; cancer; cancer chemotherapy; cell cycle S phase; cell differentiation; cell proliferation; controlled study; gene expression regulation; human; human cell; priority journal; protein targeting; tumor cell; Animals; Apoptotic Protease-Activating Factor 1; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Embryo; Humans; Mice; Promoter Regions (Genetics); Proteins; Retinoblastoma Protein; Trans-Activation (Genetics); Transcription Factors; Transcription, Genetic; Tumor Suppressor Protein p53
Moroni, M.c., Hickman, E.s., Denchi, E.l., Caprara, G., Colli, E., Cecconi, F., et al. (2001). Apaf-1 is a transcriptional target for E2F and p53. NATURE CELL BIOLOGY, 3(6), 552-558 [10.1038/35078527].
Moroni, Mc; Hickman, Es; Denchi, El; Caprara, G; Colli, E; Cecconi, F; Muller, H; Helin, K
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/53623
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 539
  • ???jsp.display-item.citation.isi??? 507
social impact